Related Experiment Video
Updated: Jun 3, 2026

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
Published on: October 28, 2020
Apical hypertrophic cardiomyopathy: correlations between echocardiographic parameters, angiographic left ventricular
Chao-Chin Chen1, Meng-Huan Lei, Yu-Cheng Hsu
1Division of Cardiology, Department of Medicine, Lo-Tung Poh-Ai Hospital, I-Lan, Taiwan. chen.stpaul@msa.hinet.net
Insights
Echocardiography can identify specific features of apical hypertrophic cardiomyopathy (ApHCM) linked to worse outcomes. Detecting cavity obliteration and paradoxical flow helps predict cardiovascular events in ApHCM patients.
Area of Science:
- Cardiology
- Medical Imaging
Background:
- Apical hypertrophic cardiomyopathy (ApHCM) can lead to apical asynergy, including sequestration or aneurysm.
- These echocardiographic findings may correlate with adverse cardiovascular outcomes.
Purpose of the Study:
- To investigate the association between echocardiographic parameters and morphological patterns of left ventriculograms with cardiovascular morbidity and mortality in ApHCM patients.
Main Methods:
- A cohort of 47 ApHCM patients was followed for 35.4 months.
- Echocardiographic measurements included hypertrophy extent/degree, cavity obliteration, and paradoxical diastolic jet flow.
- Left ventriculograms were analyzed for morphological abnormalities; cardiac catheterization was performed when consent was obtained.
Main Results:
- Of 47 patients, 30 had pure ApHCM and 17 had mixed ApHCM. Sustained cavity obliteration was observed in 28 patients, with 17 showing paradoxical flow.
- Left ventriculograms revealed "ace-of-spades" (15/31), apical sequestration (12/31), and apical aneurysm (4/31).
- Cardiovascular morbidities (21/47 patients) were linked to mixed ApHCM, cavity obliteration, and paradoxical flow. Three of four deaths were associated with apical aneurysm.
Conclusions:
- Echocardiography is crucial for detecting cavity obliteration and paradoxical flow in ApHCM.
- Differentiating pure from mixed ApHCM forms and identifying apical sequestration versus aneurysm via echocardiography is clinically important.
Background:
Echocardiographic parameters could be implicated in the development of apical asynergy (characterized by apical sequestration or apical aneurysm) and worse cardiovascular outcome in patients with apical hypertrophic cardiomyopathy (ApHCM).
Hypothesis:
Echocardiographic parameters and morphological patterns of left ventriculograms are associated with cardiovascular morbidity and mortality in patients with ApHCM.
Methods:
We followed 47 cases with echocardiographically documented ApHCM. Echocardiographic findings of the extent and degree of hypertrophy, sustained cavity obliteration, and paradoxical diastolic jet flow were measured. All patients underwent a cardiac catheterization except for the cases whose informed consent was not acquired. The clinical manifestations were assessed and recorded by the attending physicians during 35.4 ± 23.7 months follow-up.
Results:
Among the 47 patients with ApHCM, 30 patients presented as the "pure" form and 17 patients present as the "mixed" form. Seventeen of 28 patients with sustained cavity obliteration showed paradoxical flow by echocardiography. Thirty-one underwent left ventriculograms and showed morphological abnormalities, including "ace-of-spades" configuration (15/31), apical sequestration (12/31), and apical aneurysm (4/31). The results demonstrated that cardiovascular morbidities occurred in 21 of 47 patients and were closely related to the presence of mixed form ApHCM, cavity obliteration, and paradoxical flow by univariate and multivariate Cox analysis. During the period of follow-up, 4 patients (9.5%) died, and among them 3 had concomitant apical aneurysm.
Conclusions:
We concluded that detection of cavity obliteration and paradoxical flow and discrimination of pure form from mixed form by echocardiography, as well apical sequestration from apical aneurysm in ApHCM patients, is warranted.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Cardiomyopathy V: Interprofessional Care
Mitral Stenosis II: Clinical features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy II: Dilated Cardiomyopathy
